Trevi Therapeutics, Inc.TRVINASDAQ
Loading
Debt to Equity Over TimeCompressed
Percentile Rank11
3Y CAGR-63.6%
5Y CAGR-62.0%
Studio
Year-over-Year Change

Debt-to-equity ratio

3Y CAGR
-63.6%/yr
vs +7.8%/yr prior
5Y CAGR
-62.0%/yr
Consistent
Acceleration
-71.4pp
Decelerating
Percentile
P11
Within normal range
vs 5Y Ago
0x
Contraction
Streak
4 yr
Consecutive declineCompressed
PeriodValueYoY Change
20250.00-60.3%
20240.01-36.1%
20230.02-81.0%
20220.09-90.0%
20210.86+64.5%
20200.52+7880.9%
20190.01-89.7%
20180.06-82.3%
20170.36+128.2%
2016-1.27-